JMP Securities has recently reduced Notable Labs Ltd (NTBL) stock to Mkt Perform rating, as announced on September 20, 2024, according to Finviz. Earlier, on July 20, 2022, Oppenheimer had reduced the stock from a Outperform to Perform. H.C. Wainwright also reduced Neutral rating. Additionally, Oppenheimer resumed Outperform rating on July 18, 2022, with a target price of $5.50. Chardan Capital Markets analysts, in their report published on April 28, 2022, also initiated Buy rating and set a price target of $5 for Notable Labs Ltd’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Notable Labs Ltd (NTBL) Stock Trading Recap
On Friday, Notable Labs Ltd (NTBL) stock saw a decline, ending the day at $0.31 which represents a decrease of $-0.07 or -18.42% from the prior close of $0.38. The stock opened at $0.3 and touched a low of $0.28 during the day, reaching a high of $0.35. The volume of shares traded was 5.03 million exceeding the average volume of 2.45 million.
Sponsored
NTBL Stock Performance and Moving Averages
In recent trading, Notable Labs Ltd (NTBL) stock price has shown some volatility, fluctuating -19.48% over the last five trades and -31.57% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -68.04%, and it has plunged by -56.94% in the previous three months. Currently, NTBL is trading at -21.48%, -34.72%, and -66.84% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, NTBL, a Healthcare sector stock, is trading -93.03% below its 52-week high but remains 40.91% above its 52-week low. The Average True Range (ATR) (14 days) of 0.08 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Notable Labs Ltd’s Profitability and Valuation Ratios
Notable Labs Ltd’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -3398.54% with a gross margin of -68.04%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Notable Labs Ltd’s market capitalization stands at $2.99 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Book Ratio is 0.42, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 46.46% of Notable Labs Ltd (NTBL)’s shares, while financial institutions hold 1.11%.
